𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

✍ Scribed by Tavernier, E; Boiron, J-M; Huguet, F; Bradstock, K; Vey, N; Kovacsovics, T; Delannoy, A; Fegueux, N; Fenaux, P; Stamatoullas, A

Book ID
110058334
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
166 KB
Volume
21
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome after first relapse in children
Outcome after first relapse in children with acute lymphoblastic leukemia: A population-based study of 315 patients from the nordic society of pediatric hematology and oncology (NOPHO)
✍ Schroeder, H. ;Garwicz, S. ;Kristinsson, J. ;Siimes, M. A. ;Wesenberg, F. ;Gusta 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

## Abstract This study reports the outcome after relapse of acute lymphoblastic leukemia (ALL) in a population‐based study of 809 children over 1 year of age diagnosed July 1981 through June 1986 and with non‐B acute lymphoblastic leukemia in the five Nordic countries. By January 1994, 315 children

The extent of minimal residual disease r
The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af